BOLTON SECURITIES CORPORATION’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.97K	Buy	+45	New	+$1.99K	﹤0.01%	1729

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.73B AUM 18.92% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.28% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's XPH Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2025: 45 shares worth $1.97K. The stake represents ﹤0.01% of the portfolio and ranks #1729 among its holdings.

71 funds tracked by Wall St. Rank hold XPH as of Q1 2025.

BOLTON SECURITIES CORPORATION held 45 shares of State Street SPDR S&P Pharmaceuticals ETF worth $1.97K as of Q1 2025.
State Street SPDR S&P Pharmaceuticals ETF was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #1729 holding.
71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.